BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19557625)

  • 1. 'Rapping' on the door of drug resistance.
    Rund D
    Leuk Lymphoma; 2009 Jul; 50(7):1065-6. PubMed ID: 19557625
    [No Abstract]   [Full Text] [Related]  

  • 2. As easy as ABC: scientists fish out another drug resistance gene.
    Kuska B
    J Natl Cancer Inst; 1999 Mar; 91(5):402-4. PubMed ID: 10070934
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of drug resistance.
    Biedler JL; Spengler BA
    Cancer Treat Res; 1994; 73():1-16. PubMed ID: 7710901
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidrug resistance reversal in childhood malignancies--potential for a real step forward?
    Pinkerton CR
    Eur J Cancer; 1996 Apr; 32A(4):641-4. PubMed ID: 8695268
    [No Abstract]   [Full Text] [Related]  

  • 5. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
    Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance.
    Kaye SB
    Cancer Treat Rev; 1990 Dec; 17 Suppl A():37-43. PubMed ID: 1982642
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug resistance: can new drugs help chemotherapy score against cancer?
    Goldman B
    J Natl Cancer Inst; 2003 Feb; 95(4):255-7. PubMed ID: 12591977
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of apoptosis are retained in cells with P glycoprotein-mediated drug resistance.
    Paleeva AG; Onishchenko GE; Shtil AA
    Dokl Biol Sci; 2006; 407():187-91. PubMed ID: 16739490
    [No Abstract]   [Full Text] [Related]  

  • 9. Complex formation between metabolic enzymes in tumor cells: unfolding the MDR1-IDE paradigm.
    Radulescu RT; Poznic M; Pavelic K
    Mol Cancer Ther; 2009 Nov; 8(11):3171. PubMed ID: 19825794
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular indicators of prognosis in mantle cell lymphoma in the era of R-hyper-CVAD: still an open issue.
    Morabito F; Gentile M
    Leuk Lymphoma; 2007 Aug; 48(8):1461-2. PubMed ID: 17701572
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: How does the MRP/GS-X pump export doxorubicin?
    Broxterman HJ; Heijn M; Lankelma J
    J Natl Cancer Inst; 1996 Apr; 88(7):466-8. PubMed ID: 8618244
    [No Abstract]   [Full Text] [Related]  

  • 12. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unanswered questions about multidrug resistance.
    Beck WT
    Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of P-glycoprotein in drug resistance in multiple myeloma.
    Abraham J; Salama NN; Azab AK
    Leuk Lymphoma; 2015 Jan; 56(1):26-33. PubMed ID: 24678978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials of P-glycoprotein reversal in solid tumours.
    Ferry DR; Traunecker H; Kerr DJ
    Eur J Cancer; 1996 Jun; 32A(6):1070-81. PubMed ID: 8763349
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors for risk-adapted therapy in chronic lymphocytic leukemia - the search continues.
    Herishanu Y; Wiestner A
    Leuk Lymphoma; 2007 Aug; 48(8):1468-9. PubMed ID: 17701575
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug resistance: overcoming the good, the bad, and the ugly.
    Rund D
    Leuk Lymphoma; 2010 Oct; 51(10):1771-2. PubMed ID: 20846098
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological considerations in the modulation of multidrug resistance.
    Fisher GA; Lum BL; Hausdorff J; Sikic BI
    Eur J Cancer; 1996 Jun; 32A(6):1082-8. PubMed ID: 8763350
    [No Abstract]   [Full Text] [Related]  

  • 19. Vincristine: Can its therapeutic index be enhanced?
    Moore A; Pinkerton R
    Pediatr Blood Cancer; 2009 Dec; 53(7):1180-7. PubMed ID: 19588521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy.
    Azzariti A; Porcelli L; Quatrale AE; Silvestris N; Paradiso A
    Curr Drug Metab; 2011 Oct; 12(8):713-21. PubMed ID: 21434858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.